Financhill
Back

Krystal Biotech Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
34

KRYS
Krystal Biotech

Last Price:
171.16
Seasonality Move:
17.47%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Krystal Biotech Price Quote

$171.16
-5.23 (-2.97%)
(Updated: November 4, 2024 at 3:55 PM ET)

Krystal Biotech Key Stats

Sell
34
Krystal Biotech (KRYS) is a Sell

Day range:
$170.82 - $176.49
52-week range:
$93.95 - $219.34
Dividend yield:
0%
P/E ratio:
452.28
P/S ratio:
30.95
P/B ratio:
6.04%

Volume:
296.9K
Avg. volume:
160.4K
1-year change:
47.84%
Market cap:
$5.1B
Revenue:
$50.7M
EPS:
$3.66

How Much Does Krystal Biotech Make?

Is Krystal Biotech Growing As A Company?

Data Unavailable

Krystal Biotech Stock Price Performance

  • Did Krystal Biotech Stock Go Up Last Month?
    Krystal Biotech share price went down by -2.8% last month
  • Did KRYS's Share Price Rise Over The Last Year?
    KRYS share price rose by 47.84% over the past 1 year

What Is Krystal Biotech 52-Week High & Low?

Krystal Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Krystal Biotech?

  • How Much Debt Does Krystal Biotech Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Krystal Biotech Have?
    Cash and short term investments quarterly total is $559.6M
  • What Is Krystal Biotech’s Book Value Per Share?
    Book value per share is 29.22

Is Krystal Biotech Cash Flow Positive?

  • What Is KRYS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$16.7M
  • What Is Krystal Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $37.2M
  • What Is Krystal Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $49.7M

Krystal Biotech Return On Invested Capital

  • Is Management Doing A Good Job?
    KRYS return on invested capital is 13.36%
  • What Is Krystal Biotech Return On Assets?
    ROA measures how assets are converting to revenues and is 12.54%
  • What Is KRYS Return On Equity?
    ROE is a measure of profitability and is 13.85%

Krystal Biotech Earnings Date & Stock Price

Krystal Biotech Competitors

  • Who Are Krystal Biotech's Competitors?
    Below is a list of companies who compete with Krystal Biotech or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Axsome Therapeutics Inc (AXSM)
    • Bioventus Inc (BVS)
    • Amicus Therapeutics Inc (FOLD)
    • Sarepta Therapeutics Inc (SRPT)

Krystal Biotech Dividend Yield

Krystal Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.88%
Revenue: 0% 7.36%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 207.22
Upside from Last Price: 17.48%

Major Shareholders

  • How many KRYS shares are owned by institutional investors?
    52.9M KRYS shares are owned by institutional investors
  • How many KRYS shares are owned by insiders?
    3.4M KRYS shares are owned by insiders